PhoenixBio Co. saw a strong rally this week, closing at 611.00 on February 21, marking an increase of 100.00 points, or 19.57%, from its previous close of 511.00. The stock opened at 611.00 and remained stable throughout the week, with no fluctuations in its trading range.
Trading volume stood at 38,200, significantly higher than the average volume of 17,918, indicating heightened investor interest. The company’s market capitalization now stands at 2.475 billion. However, PhoenixBio Co. reports negative earnings per share (EPS) at -31.47, with no recorded price-to-earnings (PE) ratio.
The stock reached its new 52-week high of 611.00 this week, with its 52-week range spanning from 318.00 to 611.00.
Disclaimer: This article is for informational purposes only and does not constitute financial advice.